Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196


Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample.

Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, Yusuf S, Zinman B, Harris SB, Hanley AJ, Connelly PW, Huff MW, Hegele RA.

BMC Med Genet. 2007 Dec 20;8:80.


Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample.

Al-Attar SA, Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, Yusuf S, Zinman B, Harris SB, Hanley AJ, Connelly PW, Huff MW, Hegele RA.

Cardiovasc Diabetol. 2008 Mar 13;7:5. doi: 10.1186/1475-2840-7-5.


Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.

Niculescu LS, Vlădică M, Sima AV.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):587-91. doi: 10.1016/j.bbrc.2009.11.103.


Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A; GREECE-METS Collaborative Group..

Int J Cardiol. 2007 Apr 25;117(2):204-10.


Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease.

Olivieri O, Bassi A, Stranieri C, Trabetti E, Martinelli N, Pizzolo F, Girelli D, Friso S, Pignatti PF, Corrocher R.

J Lipid Res. 2003 Dec;44(12):2374-81.


APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.

Miller M, Rhyne J, Chen H, Beach V, Ericson R, Luthra K, Dwivedi M, Misra A.

Arch Med Res. 2007 May;38(4):444-51.


Lipid profiles and associated gene polymorphisms in young Asian Indian patients with acute myocardial infarction and the metabolic syndrome.

Ranjith N, Pegoraro RJ, Rom L.

Metab Syndr Relat Disord. 2009 Dec;7(6):571-8. doi: 10.1089/met.2009.0015.


The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.

Luk AO, Ma RC, So WY, Yang XL, Kong AP, Ozaki R, Ko GT, Chow CC, Cockram CS, Chan JC, Tong PC.

Diabet Med. 2008 Dec;25(12):1419-25. doi: 10.1111/j.1464-5491.2008.02602.x.


The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals.

Montagnana M, Fava C, Nilsson PM, Engström G, Hedblad B, Lippi G, Minuz P, Berglund G, Melander O.

Diabet Med. 2008 Aug;25(8):902-8. doi: 10.1111/j.1464-5491.2008.02510.x.


The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides.

Dallongeville J, Cottel D, Wagner A, Ducimetière P, Ruidavets JB, Arveiler D, Bingham A, Ferrières J, Amouyel P, Meirhaeghe A.

BMC Med Genet. 2008 Sep 12;9:84. doi: 10.1186/1471-2350-9-84.


APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica.

Ruiz-Narváez EA, Yang Y, Nakanishi Y, Kirchdorfer J, Campos H.

J Lipid Res. 2005 Dec;46(12):2605-13.


Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome.

Koutsovasilis A, Protopsaltis J, Triposkiadis F, Kokkoris S, Milionis HJ, Zairis MN, Skoularigis J, Koukoulis G, Korantzopoulos P, Melidonis A, Foussas SG.

Intern Med. 2009;48(4):179-87.


The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.

Valenti L, Nobili V, Al-Serri A, Rametta R, Leathart JB, Zappa MA, Dongiovanni P, Fracanzani AL, Alterio A, Roviaro G, Daly AK, Fargion S, Day CP.

J Hepatol. 2011 Dec;55(6):1409-14. doi: 10.1016/j.jhep.2011.03.035.


Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.

Chien KL, Hsu HC, Chen YC, Su TC, Lee YT, Chen MF.

Transl Res. 2009 Sep;154(3):133-41. doi: 10.1016/j.trsl.2009.06.005.


Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome.

Esteve E, Villuendas G, Mallolas J, Vendrell J, López-Bermejo A, Rodríguez M, Recasens M, Ricart W, San Millán JL, Escobar-Morreale H, Richart C, Fernández-Real JM.

Clin Endocrinol (Oxf). 2006 Jul;65(1):88-91.


APOA5 variants and metabolic syndrome in Caucasians.

Grallert H, Sedlmeier EM, Huth C, Kolz M, Heid IM, Meisinger C, Herder C, Strassburger K, Gehringer A, Haak M, Giani G, Kronenberg F, Wichmann HE, Adamski J, Paulweber B, Illig T, Rathmann W.

J Lipid Res. 2007 Dec;48(12):2614-21.


Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.

Li WJ, Xue H, Sun K, Song XD, Wang YB, Zhen YS, Han YF, Hui RT.

Chin Med J (Engl). 2008 Aug 20;121(16):1532-6.


Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and "insulin-resistant" T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction.

Olivieri O, Martinelli N, Sandri M, Bassi A, Guarini P, Trabetti E, Pizzolo F, Girelli D, Friso S, Pignatti PF, Corrocher R.

Clin Chem. 2005 Feb;51(2):360-7.

Items per page

Supplemental Content

Support Center